Shares of Health Care sector company Eledon Pharmaceuticals moved -5.1% today, and are now trading at a price of $1.12. The small-cap stock's daily volume was 50,748 compared to its average volume of 90,028. The S&P 500 index returned a -0.0% performance.
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company is based in Irvine and has 17 full time employees. Its market capitalization is $27,101,872.
5 analysts are following Eledon Pharmaceuticals and have set target prices ranging from $7.0 to $39.0 per share. On average, they have given the company a rating of buy. At today's prices, ELDN is trading -92.82% away from its average analyst target price of $15.6 per share.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | -39,876 | nan | -39,876 | -40.29 |
| 2022 | -28,424 | nan | -28,424 | 1.69 |
| 2021 | -28,913 | nan | -28,913 | -90.07 |
| 2020 | -15,212 | nan | -15,212 | -9.78 |
| 2019 | -13,857 | nan | -13,857 | -16.51 |
| 2018 | -11,893 | nan | -11,893 |
